期刊文献+

抗癌药1,4-二[2-(二甲胺基)乙胺基]-5,8-二羟基蒽醌的合成研究 被引量:1

Study on the synthesis of anti-tumor agent 1,4-Bis {(dimethylamino) ethyl]amino}-5,8-dihydroxyanthraquinone
下载PDF
导出
摘要 以2,3-二氢-1,4,5,8-四羟基蒽醌和N,N-二甲基乙二胺为原料,合成了抗癌药物1,4-二[2-(二甲胺基)乙胺基]-5,8-二羟基蒽醌(下称:AQ4),考察了温度、溶剂、催化剂、氧化方式等对其产品收率的影响.确定的较佳工艺方法为:以2,3-二氢-1,4,5,8-四羟基蒽醌和N,N-二甲基乙二胺为起始原料进行缩合反应,用N,N-二甲基乙二胺兼做溶剂,首先制得1,4-二[2-(二甲胺基)乙胺基]-5,8-二羟基蒽醌隐色体(AQ4隐色体),进而用硝基苯进行氧化反应制得AQ4,产品总收率达到67.5%,产品结构利用红外(IR)、核磁(。HNMR)进行了表征.较佳的缩合反应条件为:反应温度50~55℃、反应时间2h;较佳的氧化反应条件为:反应温度140~145℃、回流反应时间15min. The synthesis of 1,4-Bis { [ 2- (dimethylamino) ethyl ] amino 1-5,8-dihydroxyanthraquinone ( AQ4 ) was studied as antitumor agent in this paper with 2,3-dihydro-1,4,5,8-tetrahydroxyanthraquinone and N, N-dimethylaminoethylamine as raw materials. The reaction conditions, such as the reaction temperature, the solvents, the catalysts and the oxidizing agents were optimized. The optimized reactive conditions was that condensation of 2,3-dihydro-1,4,5,8-tetrahydroxyanthraquinone with a large excess amount of N, N-dimethylaminoethylamine as solvent at 50 - 55 ℃ for 2 h, followed by nitrobenzene oxidation of the dihydro intermediate at 140 - 145 ℃ for 15min get AQ4 with the yield of 67.5%. The product has been charactered by IR and ^1H NMR.
出处 《天津理工大学学报》 2007年第1期4-7,共4页 Journal of Tianjin University of Technology
基金 国家自然科学基金(20376063) 天津市自然科学基金(043610511)
关键词 2 3-二氢-1 4 5 8-四羟基蒽醌 N N-二甲基乙二胺 抗癌药物 1 4-二[2-(二甲胺基)乙胺基]-5 8-二羟基蒽醌 2,3-dihydro-1,4,5,8-tetrahydroxyanthraquinone N, N-dimethylaminoethylamine antitumor drug 1,4-Bis { [ 2- (dimethylamino) ethyl ] amino 1-5,8-dihydroxyanthraquinone
  • 相关文献

参考文献8

  • 1[1]Patterson L H,Mckeown S R.AQ4N:A new approach to hypoxia-activated cancer chemotherapy[J].British Journal of Cancer,2000,83 (12):1589-1593.
  • 2[2]Patterson L H,Mckeown S R,Ruparelia K.Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N,a bioreductiely activated anti-tumour agent[J].British Journal of Cancer,2000,82(12):1984-1990.
  • 3[3]Wilson W R,Denny W A,Pullen S M.Tertiary amina Noxides as bioreductive drugs:DADC N-oxide,nitracrine N-oxide and AQ4N[J].Buitish Journal of Cancer,1996,74,43-47.
  • 4[4]Bronwyn G S,Kevin O H,Susan M P.Comparision of Aromatic and Tertiary Amine N-oxide of Acridine DNA Intercalaters as Bioreductive Drugs[J].Biochemical Pharmacology,2000,60:960-978.
  • 5[5]Paul J Smith,Rodwige Desnoyers.Flow cytometric analysis and confocal imaging of anticanaer alkylaminoanthraquinones and their N-Oxides in intact human cells using 647-nm krypton laser excitation[J].Wiley-Liss,Inc.,1997,27:43-53.
  • 6[6]Murdock K C,Child R G.AntitumorAgents.1,4-Bis[(aminoalkyl) amino]-9,10-anthracenediones[J].J.Med.Chem,1979,22 (9):1024-1030.
  • 7[7]William Alexander Denny,Ho Huat Lee.Synthetic method.United States Patent US,6,320,063 B1[P],1999-07-20.
  • 8[8]Ho H.Lee,William A.Denny.A large-scale synthesis of the bioreductive drug 1,4-Bis {[2-(dimethylamino)ethyl] amino }-5,8-dihydroxyanthracene-9,10-dione bisN-oxide (AQ4N)[J].J-Chem.Soc.,Perkin Trans,1999(1):2755-2758.

同被引文献28

  • 1张昱,卢俊瑞.作为潜在抗癌试剂的单取代(环氧丙烷氨基)蒽醌的合成(英文)[J].天津理工大学学报,2006,22(1):13-15. 被引量:1
  • 2Liang ZJ,Ai J,Ding X,et al.Anthraquinone derivatives\sas potent inhibitors of c-Met kinase and the extracellular\ssignaling pathway[J].ACS Medicinal Chemistry Letters,2013,4(4):408.
  • 3Martyanov TP,Ushakov EN,Klimenko LS.Effect of interchromophoric stacking interactions on the stability of\sthe sandwich-type complexes of 1-hydroxy-9,10-anthraquinone-9-iminobenzo-15-crown-5 ether with metal cat-ions[J].Macroheterocycles,2013,6(3):240.
  • 4Chang MY,Tai HY.Synthesis of 2-substituted 9,10-anthraquinones[J].Synthetic Communications,2013,43(24):3 363.
  • 5Abu N,Akhtar MN,Ho WY,et al.3-bromo-1-hydroxy-9,10-anthraquinone(BHAQ)inhibits growth and migration of the human breast cancer cell lines MCF-7 and\sMDA-B231[J].Molecules,2013,18(9):10 367.
  • 6Saha K,Lam KW,Abas F,et al.Synthesis of damnacanthal,a naturally occurring 9,10-anthraquinone and its analogues,and its biological evaluation against five cancer\scell lines[J].Medicinal Chemistry Research,2013,22(5):2 093.
  • 7Mo YY,Hou HX,Li DR,et al.Mitochondrial protein\stargets of radiosensitisation by 1,8-dihydroxy-3-acetyl-6-methyl-9,10anthraquinone on nasopharyngeal carcinoma\scells[J].European Journal of Pharmacology,2014,doi:10.1016/j.ejphar.2014.05.027.
  • 8Akhtar MN,Zareen S,Yeap SK,et al.Total synthesis,cytotoxic effects of damnacanthal,nordamnacanthal and\srelated anthraquinone analogues[J].Molecules,2013,18(8):10 042.
  • 9Karren DB,Razina R,Louisa G,et al.Antibacterial metabolites from Australia macrofungi from the genus[J].Phytochemistry,2010,71(8/9):948.
  • 10Shrestha JP,Fosso MY,Marina Y,et al.Synthesis and\santicancer structure activity relationship investigation of\scationic anthraquinone analogs[J].European Journal of\sMedicinal Chemistry,2014,77(2):99.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部